Literature DB >> 28211971

Atypical Angelman syndrome due to a mosaic imprinting defect: Case reports and review of the literature.

Anna Le Fevre1, Jasmin Beygo2, Cheryl Silveira3, Benjamin Kamien1, Jill Clayton-Smith4, Alison Colley5, Karin Buiting2, Tracy Dudding-Byth1,6,7.   

Abstract

Angelman syndrome (AS) is characterized by severe intellectual disability, limited, or absent speech and a generally happy demeanor. The four known etiological mechanisms; deletions, uniparental disomy, imprinting defects, and UBE3A mutation all affect expression of the UBE3A gene at 15q11-q13. An atypical phenotype is seen in individuals who are mosaic for a chromosome 15q11-q13 imprinting defect on the maternal allele. These patients present with a milder phenotype, often with hyperphagia and obesity or non-specific intellectual disability. Unlike typical AS syndrome, they can have a vocabulary up to 100 words and speak in sentences. Ataxia and seizures may not be present, and the majority of individuals do not have microcephaly. Here we review the current literature and present three individuals with atypical AS caused by a mosaic imprinting defect to demonstrate why DNA methylation analysis at the SNRPN locus needs to be considered in a broader clinical context.
© 2017 Wiley Periodicals, Inc. © 2017 Wiley Periodicals, Inc.

Entities:  

Keywords:  Angelman syndrome; atypical Angelman; hyperphagia; imprinting center defect; mosaic Angelman

Mesh:

Substances:

Year:  2017        PMID: 28211971     DOI: 10.1002/ajmg.a.38072

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  7 in total

1.  Two Angelman families with unusually advanced neurodevelopment carry a start codon variant in the most highly expressed UBE3A isoform.

Authors:  Anjali Sadhwani; Neville E Sanjana; Jennifer M Willen; Stephen N Calculator; Emily D Black; Lora J H Bean; Hong Li; Wen-Hann Tan
Journal:  Am J Med Genet A       Date:  2018-05-07       Impact factor: 2.802

Review 2.  Angelman syndrome and melatonin: What can they teach us about sleep regulation.

Authors:  Daniella Buonfiglio; Daniel L Hummer; Ariel Armstrong; John Christopher Ehlen; Jason P DeBruyne
Journal:  J Pineal Res       Date:  2020-10-11       Impact factor: 13.007

3.  Clinical Characterization of Epilepsy in Children With Angelman Syndrome.

Authors:  Daiana Cassater; Mariana Bustamante; Lisa Sach-Peltason; Alexander Rotenberg; Mark Nespeca; Wen-Hann Tan; Lynne M Bird; Joerg F Hipp
Journal:  Pediatr Neurol       Date:  2021-08-31       Impact factor: 3.372

4.  Preserved expressive language as a phenotypic determinant of Mosaic Angelman Syndrome.

Authors:  Robert P Carson; Lynne Bird; Anna K Childers; Ferrin Wheeler; Jessica Duis
Journal:  Mol Genet Genomic Med       Date:  2019-08-10       Impact factor: 2.183

Review 5.  UBA6 and Its Bispecific Pathways for Ubiquitin and FAT10.

Authors:  Fengting Wang; Bo Zhao
Journal:  Int J Mol Sci       Date:  2019-05-07       Impact factor: 5.923

Review 6.  Chromosome 15 Imprinting Disorders: Genetic Laboratory Methodology and Approaches.

Authors:  Merlin G Butler; Jessica Duis
Journal:  Front Pediatr       Date:  2020-05-12       Impact factor: 3.418

7.  Atypical presentation of Angelman syndrome with intact expressive language due to low-level mosaicism.

Authors:  Ruchi Punatar; Alena Egense; Rong Mao; Melinda Procter; Michelle Bosworth; Denise I Quigley; Kathleen Angkustsiri; Suma P Shankar
Journal:  Mol Genet Genomic Med       Date:  2022-08-04       Impact factor: 2.473

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.